Company Filing History:
Years Active: 2018-2020
Title: Aurélien Jacob: Innovator in Gene Therapy
Introduction
Aurélien Jacob is a notable inventor based in Montrouge, France. He has made significant contributions to the field of gene therapy through his innovative work. His expertise and dedication have led to the development of a unique patent that enhances the production of viral vectors for therapeutic applications.
Latest Patents
Aurélien Jacob holds a patent for a "Baculovirus system for the expression of a gene therapy vector." This invention relates to a recombinant baculoviral genome that is useful for producing viral vectors for gene therapy. The system allows for the production of these vectors from a single infection, streamlining the process and improving efficiency. He has 1 patent to his name.
Career Highlights
Aurélien Jacob is currently associated with Genethon, a company dedicated to advancing gene therapy research and development. His work at Genethon has positioned him as a key player in the field, contributing to groundbreaking advancements in therapeutic technologies.
Collaborations
Throughout his career, Aurélien has collaborated with esteemed colleagues, including Lionel Galibert and Otto-Wilhelm Merten. These partnerships have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
Aurélien Jacob's contributions to gene therapy through his innovative patent and work at Genethon highlight his importance in the scientific community. His dedication to advancing therapeutic technologies continues to inspire future innovations in the field.